Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Doshi

Showing results (81-90 of 144) with videos related to

Pageof 15
Sort By:
BMJ (Clinical Research Ed.)|September 19, 2023
Industry funding and self-censorship: how many bite the hand that feeds them?Peter Doshi, Kim Witczak, Linda Wastila
BMJ (Clinical Research Ed.)|June 7, 2014
Digging for data on harms in duloxetine trialsPeter Doshi, Julie Zito, Susan dosReis
Annals of Internal Medicine|September 5, 2012
Antivirals for treatment of influenzaCarl Heneghan, Tom Jefferson, Peter Doshi
Journal of Evaluation in Clinical Practice|March 27, 2023
Sources of bias in observational studies of covid-19 vaccine effectivenessKaiser Fung, Mark Jones, Peter Doshi
JAMA Internal Medicine|December 1, 2015
The Untapped Potential of Pharmacy Leaflets for Informing Patients About Drug Benefits and RisksAnna Hung, Jan Sieluk, Peter Doshi
Journal of the American Pharmacists Association : Japha|January 22, 2019
The possible harms of statins: What do product labels, patient package inserts, and pharmacy leaflets tell us?Peter Doshi, Jan Sieluk, Anna Hung
BMJ (Clinical Research Ed.)|April 19, 2019
Canada finally opens up data on new drugs and devicesJoel Lexchin, Matthew Herder, Peter Doshi
BMJ (Clinical Research Ed.)|June 11, 2010
Child influenza vaccination. Ramifications of adverse events in children in AustraliaPeter Collignon, Peter Doshi, Tom Jefferson
BMJ (Clinical Research Ed.)|July 4, 2013
YODA and truth seeking in medicinePeter Doshi, S Swaroop Vedula, Tianjing Li
BMJ (Clinical Research Ed.)|August 26, 2020
Covid-19: Should doctors recommend treatments and vaccines when full data are not publicly available?Raymond M Johnson, Peter Doshi, David Healy
Pageof 15

Showing results (81-90 of 144) with videos related to

Sort By:
Pageof 15
BMJ (Clinical Research Ed.)|September 19, 2023
Industry funding and self-censorship: how many bite the hand that feeds them?Peter Doshi, Kim Witczak, Linda Wastila
BMJ (Clinical Research Ed.)|June 7, 2014
Digging for data on harms in duloxetine trialsPeter Doshi, Julie Zito, Susan dosReis
Annals of Internal Medicine|September 5, 2012
Antivirals for treatment of influenzaCarl Heneghan, Tom Jefferson, Peter Doshi
Journal of Evaluation in Clinical Practice|March 27, 2023
Sources of bias in observational studies of covid-19 vaccine effectivenessKaiser Fung, Mark Jones, Peter Doshi
JAMA Internal Medicine|December 1, 2015
The Untapped Potential of Pharmacy Leaflets for Informing Patients About Drug Benefits and RisksAnna Hung, Jan Sieluk, Peter Doshi
Journal of the American Pharmacists Association : Japha|January 22, 2019
The possible harms of statins: What do product labels, patient package inserts, and pharmacy leaflets tell us?Peter Doshi, Jan Sieluk, Anna Hung
BMJ (Clinical Research Ed.)|April 19, 2019
Canada finally opens up data on new drugs and devicesJoel Lexchin, Matthew Herder, Peter Doshi
BMJ (Clinical Research Ed.)|June 11, 2010
Child influenza vaccination. Ramifications of adverse events in children in AustraliaPeter Collignon, Peter Doshi, Tom Jefferson
BMJ (Clinical Research Ed.)|July 4, 2013
YODA and truth seeking in medicinePeter Doshi, S Swaroop Vedula, Tianjing Li
BMJ (Clinical Research Ed.)|August 26, 2020
Covid-19: Should doctors recommend treatments and vaccines when full data are not publicly available?Raymond M Johnson, Peter Doshi, David Healy
Pageof 15